Waring M J, González A, Jiménez A, Vázquez D
Nucleic Acids Res. 1979 Sep 11;7(1):217-30. doi: 10.1093/nar/7.1.217.
Two new antitumour drugs, imide derivatives of 3-nitro-1,8-naphthalic acid having different basic side chains linked to the imide nitrogen, have been shown to bind to double-helical DNA by intercalation. At ionic strength 0.01 mol/litre, pH 7, their intrinsic association constants are about 1.45 x 10(5) M-1 and each bound ligand molecule occludes about 3.4 nucleotides of the DNA lattice. They remove and reverse the supercoiling of closed circular duplex PM2 DNA with apparent unwinding angles of 11-12 degrees per bound drug molecule, referred to an assumed unwinding angle of 26 degrees for ethidium. They increase the viscosity of sonicated rod-like DNA fragments, each bound drug molecule producing a calculated increment in length of 2.2 - 2.5 A. No important differences between the DNA-binding characteristics of the two drugs were detected, though one appears marginally more active than the other in certain biological tests.
两种新型抗肿瘤药物,即3-硝基-1,8-萘二甲酸的酰亚胺衍生物,其酰亚胺氮上连接有不同的碱性侧链,已被证明可通过嵌入作用与双螺旋DNA结合。在离子强度0.01mol/升、pH值为7的条件下,它们的固有缔合常数约为1.45×10⁵M⁻¹,且每个结合的配体分子会占据DNA晶格中约3.4个核苷酸。它们能去除并逆转闭环双链PM2 DNA的超螺旋,每个结合的药物分子的表观解旋角度为11 - 12度,以溴化乙锭假定的26度解旋角度为参照。它们会增加超声处理后的棒状DNA片段的黏度,每个结合的药物分子使长度计算增加2.2 - 2.5埃。未检测到这两种药物在DNA结合特性上的重要差异,不过在某些生物学试验中,其中一种药物似乎比另一种略具活性。